E
TFFP

Ergoteles’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Ergoteles’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,069
Closed -$257K – 1773
2021
Q2 		$257K Buy
+1,069
New +$293K 0.01% 1146

Other funds holding TFFP

CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Ergoteles's TFFP Position: Q3 2021 in Review

Ergoteles sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q3 2021, closing a stake of 1,069 shares — an estimated $257K sold.

Ergoteles first reported a position in TFFP in Q2 2021 and held it in 1 quarter. The position peaked at $257K in Q2 2021. 54 funds tracked by Wall St. Rank hold TFFP as of Q3 2021.

  • Ergoteles reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Ergoteles sold 1,069 TFF Pharmaceuticals, Inc. Common Stock shares in Q3 2021, an estimated $257K.
  • Ergoteles first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Ergoteles's TFF Pharmaceuticals, Inc. Common Stock position peaked at $257K in Q2 2021.
  • 54 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on Ergoteles's 13F filing for Q3 2021, filed 15 Nov 2021.